Arthneeti
All Q2 FY27 results →
AH

Aatmaj Healthcare Ltd

Q2 FY27Healthcare Services

Aatmaj Healthcare Q2 Results 2026 (FY27) investor presentation: Revenue & Margins

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹24
Market cap₹53 Cr
P/E73.8
Updated29 Oct 2026
Read3 min read

Based on Aatmaj Healthcare Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Revenue from operations for H1 FY 26-27: ₹1,695.98 million vs ₹1,081.04 million in H1 FY 25-26, reflecting a 54% growth (Page 13 & 14).

From Aatmaj Healthcare Ltd's Q2 FY27 earnings-call transcript · updated 29 Oct 2026.

Revenue & Sales Performance

  • Revenue from operations for H1 FY 26-27: ₹1,695.98 million vs ₹1,081.04 million in H1 FY 25-26, reflecting a 54% growth (Page 13 & 14).
  • Total revenue for H1 FY 26-27: ₹1,738.52 million (including other income).
  • Strong inpatient growth driven by surgical volumes, improved occupancy, and specialty care contributed to revenue increase (Page 14).
  • Outpatient and diagnostics surged due to Anand Shri Laboratory integration (Page 14).
  • Average Revenue Per Occupied Bed (ARPOB) increased to ₹24,500+ (Page 16).
  • Expected revenue growth for H2 FY 26-27 is approximately 40% (Page 15).

2 more points from Aatmaj Healthcare Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Aatmaj Healthcare Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Commissioned Cardiothoracic & Vascular Surgery (CTVS) department at Jupiter Hospital, Vadodara (operational as of H1 FY26-27).
  • Increased capacity of Adult Critical Care Unit and Neonatal Intensive Care Unit (N.I.C.U.) at Jupiter Hospital, Vadodara.
  • Launched JTP IVF & Fertility Centre at Tirth Hospital, Kareli Baug, Vadodara.
  • Integrated Anand Hospital along with Anand Shri Laboratory and Pharmacy network at Nizampura, Vadodara (completed integration).
  • Expansion focused on increasing operational bed strength to 250+ beds with current occupancy ~65-70%.
  • Future growth via hub & spoke model deepening presence in Gujarat and M.P., including feeder clinics connected to tertiary hospital hubs.

2 more points from Aatmaj Healthcare Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
1Health X Platform
Rev 1Mar 1
2Chandan Healthca
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 2
5
Rev 2Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Aatmaj Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Aatmaj Healthcare Ltd said on order book & pipeline — free account, 30 seconds.

Continue your research

What Aatmaj Healthcare Ltd's management said in earlier quarters

Others in Healthcare Services this season

  • Narayana Hrudayalaya Ltd (Q2 FY27)

    Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27

  • Artemis Medicare Services Ltd (Q2 FY27)

    Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service

  • Max Healthcare Institute Ltd (Q2 FY27)

    Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio

  • Indegene Ltd (Q2 FY27)

    Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4) . Key investor presentation takeaways from Indegene Ltd's Q2 FY27 investo

Compare:vs Apollo Hospitals Enterprise Ltdvs Manipal Health Enterprises Ltdvs Max Healthcare Institute Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Aatmaj Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Aatmaj Healthcare Ltd Q2 FY27 results?

Revenue from operations for H1 FY 26-27: ₹1,695.98 million vs ₹1,081.04 million in H1 FY 25-26, reflecting a 54% growth (Page 13 & 14).

What is Aatmaj Healthcare Ltd share price analysis?

Aatmaj Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 73.8 with a market cap of ₹53 Cr. Investors should review the full earnings analysis for detailed insights.

Is Aatmaj Healthcare Ltd planning capital expenditure?

Commissioned Cardiothoracic & Vascular Surgery (CTVS) department at Jupiter Hospital, Vadodara (operational as of H1 FY26-27).

Keep Aatmaj Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.